Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial
2 Long-term efficacy and safety of ixekizumab: 5-year analysis of the UNCOVER-3 randomized controlled trial
3 Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study
4 Analysis from Phase 3 ATTR-ACT and Its Long-Term Extension Study Demonstrates VYNDAQEL® 80 mg/VYNDAMAX® 61 mg Significantly Improved Survival in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Compared to VYNDAQEL 20 mg
5 Case: Patents/Obviousness & Indefiniteness (D. Del.)
6 Lyrica: Generic, side effects, dosage, alternatives, and more
7 Impossible Foods and Feeding America® Fight to End Hunger With “Buy Impossible Burger, Give Impossible Burger” Holiday Campaign
8 Lisinopril: Uses, Side Effects, Dosages, and Precautions
9 A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, vs paclitaxel alone for refractory or recurrent ovarian cancer
10 The Health Benefits of Coffee
11 Ixekizumab demonstrates long-term efficacy
12 Accupril (Quinapril): Uses, Side Effects, Dosages
13 Dapagliflozin Plus Verinurad and Febuxostat Reduces Serum Uric Acid Without Affecting Kidney Function
14 Angelini Pharma and Sunovion Pharmaceutical Europe receive EMA approval for Latuda, first Atypical Antipsychotic for the Treatment of Adolescent Schizophrenia in patients starting from 13 years of age
15 Pravachol: Side effects, uses, dosage, alternatives, and more
16 FDA Approves Reduced Frequency Durvalumab Dosing Option in NSCLC
17 AbbVie and Eisai Announce an approval for additional indication of HUMIRA®, a fully Human Anti-TNFα Monoclonal Antibody, for the treatment of pyoderma gangrenosum for the first time in the world | Antibodies | News Channels
18 Hydrogen-based decarbonisation of industrial furnaces
19 Ionis and Akcea announce that Pfizer has initiated a Phase 2b clinical study of vupanorsen (AKCEA-ANGPTL3-LRx)
20 Dr. Roach: Can a food supplement help with GERD?
21 OPP briefs: Drug charges, UOV Festive R.I.D.E week one results
22 Madrigal Pharmaceuticals Announces Completion of Enrollment in Phase 3 MAESTRO NAFLD-1 Trial and Reports 2020 Third Quarter Financial Results and Highlights
23 Study: Zinc hydroxychloride minerals can improve performance when fed to pigs at zinc levels below EU regulations
24 Vancomycin Dosing Guidelines: Where Do We Go From Here?
25 The US Government Provides Critical Support to the Turtle Survival Alliance
26 Madrigal Pharmaceuticals Highlights Presentations at The Liver Meeting Digital Experience™, The American Association for the Study of Liver Diseases Meeting November 13, 2020, Including NASH Expert Insights on the Ongoing Open Label Arm of Resmetirom 52-Week Phase 3 MAESTRO-NAFLD-1 Trial
27 Role of HER2-Directed Therapies Rapidly Evolves in Esophageal and Gastric Cancer
28 Guelph driver, 18, charged with impaired driving in Georgian Bluffs
29 5 Foods To Help Toddlers & Kids Sleep
30 Infliximab in infantile Takayasu arteritis: a case report and literature review
31 Capillary leakage provides nutrients and antioxidants for rapid pneumococcal proliferation in influenza-infected lower airways
32 Study suggests honey and Nigella sativa expedites viral clearance in COVID-19 patients
33 Celltrion's CT-P17 Adalimumab Biosimilar Candidate Demonstrates Equivalence
34 The festive RIDE campaign commences this weekend
35 Judge sentences three Montague men to jail for impaired driving
36 Experts Release First Exercise Guide for People with Type 1 Diabetes
37 LOS ANGELES – Home delivery has become the sign of the times for food and cannabis in this pandemic and s
38 The US Government and the National Malaria Control Program Launch Indoor Spraying Campaign to Prevent Malaria
39 Cara Therapeutics Completes Full Enrollment in KARE Phase 2 Trial of Oral KORSUVA™ in Atopic Dermatitis Patients with Moderate-to-Severe Pruritus
40 Tackling the Global Issue of New Psychoactive Substances
41 Intravesical Bacillus Calmette Market 2020 | Strategic Assessment by Top Players like Merck, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec, Serum Institute of India, GSBPL, and More?
42 MG EP EV launched in Thailand for below 1m baht
43 Analysis Of The Non-alcoholic Steatohepatitis (NASH) Drug Pipeline Market Sizing Up The First Wave
44 Telmisartan and Hydrochlorothiazide Drug Market 2020 Insights Business Opportunities, Current Trends And Restraints Forecast 2026 : Boehringer Ingelheim, Zydus Pharmaceuticals, Mylan Pharmaceuticals, Teva, Macleods, Lupin Pharmaceuticals, Huahai Pharmaceutical
45 Peel back the mystery of onions
46 Dupixent® (dupilumab) Approved by European Commission as First and Only Biologic Medicine for Children Aged 6 to 11 Years with Severe Atopic Dermatitis | Antibodies | News Channels
47 Agios' anemia drug hits goal in phase 3, teeing up 2021 filing
48 Hyoscine butylbromide versus acetaminophen for nonspecific colicky abdominal pain in children: a randomized controlled trial
49 US Approves Imcivree for Obesity due to POMC, PCSK1, LEPR Deficiency
50 Change in BP meds caused loud, pounding pulse
51 GNC and TV Personality Jay Glazer Launch New Premium Supplement Line, UNBREAKABLE PERFORMANCE™ Fueled by GNC
52 BDR Pharma launches 80 mg version of prostate cancer drug at Rs 24,480 per pack in India
53 How important is it to start treatment for relapsing MS? Sponsored...
54 COVID-19 and Infant Hospitalizations for Seasonal Respiratory Virus Infections, New Zealand, 2020
55 FDA Grants Accelerated Approval to Naxitamab-gqgk Combo for the Treatment of Neuroblastoma
56 Common Heartburn Drug for COVID-19 Symptoms?
57 Adalimumab 80 mg Intensified Treatment Safely Improves Psoriasis Severity
58 High-Dose Tafamidis Boosts Survival in Cardiomyopathy
59 BDR Pharma unveils prostate cancer drug enzalutamide at Rs 24480 per pack in India
60 Novel Venetoclax/Decitabine Dosing Schedule Demonstrates Safety, Efficacy in Older Patients With Newly Diagnosed AML
61 Can I Take 40 mg of Cialis? And Other Options
62 Electric/Hybrid
63 Fluoride Use in Caries Prevention in the Primary Care Setting
64 Three Posters on SEL24/MEN1703 including Pharmacodynamic Data from the Dose Escalation Part of DIAMOND-01 Trial to be published at American Society of Hematology (ASH) Annual Meeting
65 Getting the Dose Just Right
66 FDA Approves Viltolarsen for Duchenne Muscular Dystrophy
67 MG Motor sets up Agra's first electric vehicle charging station
68 Lipitor: Side effects, generic, dosage, uses, and more
69 Once-Weekly Investigational MK-8507 Potent Even at Low Doses
70 Metacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital International Liver Congress™ 2020
71 Inquest finds man shot by police in Kent had been 'lawfully killed' | ITV News
72 Viibryd: Side effects, dosage, interactions, and more
73 Tocilizumab in patients with severe COVID-19: a retrospective cohort study
74 Taltz: Dosage, side effects, cost, and more
75 FDA Grants Priority Review to Adjuvant Osimertinib for EGFR-Positive NSCLC
76 Ingrezza: Side effects, dosages, uses, and more
77 BDR Pharma’s prostrate cancer drug aims to cut pill burden
78 What is the strongest CBD oil I can get?
79 5 Best Full-Spectrum CBD Oils to Buy in 2020
80 Evolocumab Helps Type 2 Diabetes Patients Reach Lipid Level Goals
81 Lupin launches cholesterol drug Atorvastatin Calcium Tablets
82 Roman ED in Review: What to Know About Their ED Treatments
83 Study Examines Cardiovascular Effects of Lasmiditan, Propranolol
84 Change in Longitudinal Level of EGFR ctDNA May Predict Benefit of Savolitinib Plus Osimertinib in NSCLC Patient Subset
85 Dr. Roach: Aggressive statin treatment won’t affect immune system
86 Selinexor combination 'extremely effective' in relapsed, refractory myeloma
87 FDA expands approval of ixekizumab for nonradiographic axial spondyloarthritis
88 Osmotica Pharmaceuticals US LLC Submits Amended NDA for Arbaclofen Extended Release Tablets to U.S. Food and Drug Administration
89 Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema
90 FDA Approves Ixekizumab (Taltz) for Nonradiographic axSpA
91 Brukinsa: Uses, side effects, interactions, and more
92 FDA Approves First Therapy for Lung and Thyroid Cancers with a Certain Genetic Alteration
93 Can fewer daily doses of cephalexin treat MSSA?
94 Fetzima: Side effects, dosages, uses, and more
95 FDA OKs Ixekizumab for Pediatric Patients with Plaque Psoriasis
96 Humira: Side effects, cost, uses, and more
97 Fitusiran Prevents Bleeds in Hemophilia A or B Over Long Term, Study Finds
98 The role of methylprednisolone on preventing disease progression for hospitalized patients with severe COVID‐19
99 FDA Approves Guardant360 CDx Liquid Biopsy for Genomic Profiling for Solid Cancers
100 Non-radiographic Axial Spondyloarthritis Treatment Taltz Approved by FDA